Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Avastin vascular endothelial growth factor

Avastin (humanized monoclonal raised against vascular endothelial growth factor). Genentech USA) Roche (EU) Carcinoma of the colon or rectum... [Pg.381]

I Biologic Therapy. Bevacizumab (Avastin, rhu-MAb VEGF) is a recombinant, humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF). Bevacizumab, in combination with intravenous fluorouracil-based chemotherapy, was approved by the FDA in 2004 for initial treatment of patients with... [Pg.2409]

Bevacizumab (Avastin) 2004 Humanized 149 2.66-3.25 L 20 days IV infusion (1.0) Vascular endothelial growth factor Colorectal cancer advanced nonsmall cell lung cancer metastatic breast cancer... [Pg.352]

See other pages where Avastin vascular endothelial growth factor is mentioned: [Pg.1010]    [Pg.1256]    [Pg.1351]    [Pg.121]    [Pg.1280]    [Pg.579]    [Pg.400]    [Pg.399]    [Pg.234]    [Pg.1010]    [Pg.1256]    [Pg.653]    [Pg.157]    [Pg.458]    [Pg.107]    [Pg.311]    [Pg.187]    [Pg.14]    [Pg.285]    [Pg.346]    [Pg.355]    [Pg.538]    [Pg.134]    [Pg.224]    [Pg.423]    [Pg.222]    [Pg.1169]    [Pg.48]    [Pg.794]    [Pg.48]   
See also in sourсe #XX -- [ Pg.121 ]



SEARCH



Avastin

Endothelial

Endothelial growth factors

Endothelialization

Vascular endothelial growth

Vascular growth

© 2024 chempedia.info